Brief: Musclepharm appoints interim CEO and President
16/03/2016 12:00
March 16 (Reuters) -
* Musclepharm founder and CEO steps down; Board Of Directors
appoints Ryan Drexler as Interim CEO and President
* Musclepharm Corp says brad Pyatt has resigned from his
position as CEO and will also leave company's Board Of
Directors
* Musclepharm Corp says company has begun a search for a
replacement that will be overseen by board
Source text for Eikon: ID:nPn9nRpnga
((Bengaluru Newsroom; +1 646 223 8780))
Recent news on MusclePharm
See all newsBrief: Musclepharm Files Voluntary Petition For Relief Under Chapter 11 Of Title 11
Brief: Musclepharm Applies To List Common Stock On Nasdaq Under Symbol 'MSLP'
Brief: MusclePharm Reports Q3 2021 Financial Results
Brief: Musclepharm Announces Colorado Distribution Partnership With New Age, Inc.
Brief: MusclePharm Q2 loss per share $0.23